MedPath

Infant Formula With Partially Hydrolyzed Cow's Milk Protein Versus a Formula With Intact Protein

Not Applicable
Conditions
Infant Colic
Interventions
Dietary Supplement: Standard formula (SF)
Dietary Supplement: Partially hydrolyzed formula (pHF)
Registration Number
NCT04015089
Lead Sponsor
Laboratorios Ordesa
Brief Summary

Randomized, parallel, double-blind clinical trial, comparing a partially hydrolyzed serum proteins infant formula with a conventional formula with intact protein in healthy infants that suffer from colic

Detailed Description

Demonstrate that an infant formula with partially hydrolized cow's milk protein of serum proteins is equivalent to an intact protein formula in healthy children in terms of safety of use and suitability, to prove that it can be a alternative with digestive health benefits in healthy children with infant colic.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
156
Inclusion Criteria
  • Children diagnosed as nursing colic according to Roma IV criteria.
  • Infants who have received breastfeeding at least 2 weeks.
  • Infants who at the time of inclusion in the study whose parents/legal guardians voluntarily decide not to continue exclusive breastfeeding or only maintain it in residual form (less than 20% of the daily intake, one breast intake per day).
  • Full-term infants (>37 weeks of gestation).
  • Infants with weight suitable for their gestational age (2500-4500g).
  • Normal APGAR score: 7-10.
  • Infants between 2 and 8 weeks of life.
  • Infants whose parents/legal guardians have signed informed consent.
  • Infants with good availability of clinical follow-up until the end of the study.
Exclusion Criteria
  • Infants fed from birth with exclusive infant formula.
  • Infants with congenital diseases or malformations that may affect growth.
  • Infants with major medical conditions that require chronic medication or close medical checks.
  • Infants who have taken any type of antibiotics or probiotics prior to the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard formula (SF)Standard formula (SF)Infants fed exclusively with a standard formula based on intact cow's milk proteins
Partially hydrolyzed formula (pHF)Partially hydrolyzed formula (pHF)Infants fed exclusively with a infant formula based on partially hydrolyzed serum cow's milk proteins.
Primary Outcome Measures
NameTimeMethod
Growth standard calculated z-scoresFrom baseline to 3 months after starting with the formula

Using Z-scores including: weight (g), size (cm) and cranial perimeter (cm)

Symptoms associated with infant colicFrom baseline to 3 months after starting with the formula

Hours of crying, wakefulness, sleep for 24 hours, by adapting Barr's crying letter

Secondary Outcome Measures
NameTimeMethod
Growth standard calculated z-scoresAt 6, 9 and 12 months old.

Using Z-scores including: weight (g), size (cm) and cranial perimeter (cm)

Product safetyAt 1, 2 and 3 months follow-up visit, and 6, 9 months old

Assessment of acceptance of the formula and record of potential adverse or side effects related to taking the product.

Assessment of supplementary foodAt 6 and 9 months old

Investigator will collect data from the timetable for introduction of the different food groups

Infant illness and infection outcomesBaseline, 1, 2 and 3 months follow-up visit, and 6, 9 months old

Specific parent-reported infant symptoms (digestive, respiratory or other infections)

Behaviour/temperament test1, 6, 12 months old

Infant Behavior Questionnaire-Revised test: For this study, the very short form validated in Spanish that includes 37 items will be applied. Parents are asked to rate the frequency of specific, temperament-related behaviors observed during the last week.

Gatrointestinal tolerance recordingBaseline, 1, 2 and 3 months follow-up visit, and 6, 9 months old

Record in the patient's diary stool patterns (depositional rhythm and quality of faeces)

Food survey at the first year of lifeAt 12 months old

Investigator will conduct a food consumption frequency survey

Trial Locations

Locations (2)

Fundació Hospital de Nens

🇪🇸

Barcelona, Spain

Consorci Sanitari de Terrassa

🇪🇸

Terrassa, Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath